Therapeutic Efficacy of "Abroma Agusta" in HbA1c % in NIDDM
ConditionType II Diabetes Mellitus
Trial statusAvailable
Trial phaseNot listed
Trial typeExpanded Access
Biological sexAll
Age30-85
SponsorFr Muller Homoeopathic Medical College
About this trial
Objective: To ascertain whether homoeopathic medicine ABROMA AUGUSTA has a clinical role in changing the Glycated Hb Level in Diabetes mellitus Type II.
Abstract:
Background: Type 2 diabetes mellitus (T2DM) is one of the most important epidemic diseases in the world in this century, and accounts for 90% of cases of diabetes globally. Studies have suggested that Abroma Augusta plays a role in acute controlling blood glucose level. The aim of this study was to evaluate the efficacy of "Abroma Augusta Ѳ" in chronic control through GlycatedHb (HbA1c %) in Diabetes Mellitus Type 2 (NIDDM) as a pretest post-test study.
Eligibility criteria
Qualifiers
None
Disqualifiers
Patient with major complications like diabetic retinopathy and cardiomyopathy. IDDM HbA1c above 11%
Trial design
Treatments tested in this trial
- Abroma Augusta Q (mother tincture)
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov